Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

9. References

1. Alegre-Díaz, Herrington, López-Cervantes et al. Diabetes and cause-specific mortality in Mexico City. New Engl J Med 2016; 375: 1961-1971.

2. Herrington, Alegre-Díaz, Wade et al. Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study. Lancet Diab Endocrinol 2018; 6: 455-463.

3. Bragg, Kuri-Morales, Berumen et al. Diabetes and infectious disease mortality in Mexico City. BMJ Open Diab Res Care 2023; 11: e003199.

4. Bragg, Kuri-Morales, Trichia et al. Type 2 diabetes and cause-specific mortality in Mexico City: a Mendelian randomization analysis. Lancet Reg Health Am 2025; 45: 101082.

5. Fermín-Martínez, Yaxmehen Bello-Chavolla, Daniel Paz-Cabrera et al. Prediabetes and risk of all-cause and cause-specific mortality: a prospective study of 114,062 adults in Mexico City. J Clin Endocrinol Metab 2025; 110(12): 3451-.

6. Bragg, Alegre-Diaz, Trichia et al. Metabolomic profile of genetic liability to type 2 diabetes among 125,000 Mexican adults: a Mendelian randomisation study. Diabetes Care 2026; 49(5): 826-834.

7. Gnatiuc, Alegre-Díaz, Wade et al. General and abdominal adiposity and mortality in Mexico City: prospective study of 150 000 adults. Ann Int Med 2019; 171: 397-405

8. Gnatiuc, Tapia-Conyer, Wade et al. Abdominal and gluteo-femoral markers of adiposity and risk of vascular-metabolic mortality in a prospective study of 150 000 Mexican adults. Eur J Prev Cardiol 2022: 29(5); 730-8.

9. Alegre-Díaz, Friedrichs, Ramirez-Reyes et al. Body mass index and COVID-19 mortality: prospective study of 120 000 Mexican adults. Int J Epidemiol 2022;51(5):1698-700.

10. Gnatiuc Friedrichs, Wade, Alegre-Díaz etal. Body Composition and Risk of Vascular-Metabolic Mortality Risk in 113 000 Mexican Men and Women Without Prior Chronic Disease. J Am Heart Assoc 2023; 12(3): e028263.

11. Gnatiuc Friedrichs, Kuri-Morales, Trichia, et al. A Mendelian Randomization study of the effect of body mass index on 52 causes of death among 125,000 Mexican adults with admixed ancestry. Int J Epidemiol 2025: 54; 4: dyaf110.

12. Tapia-Conyer, Alegre-Díaz, Gnatiuc et al. Association of blood pressure with cause-specific mortality in Mexican adults. JAMA Network Open. 2020; 3: e201814.

13. Turner, Kuri-Morales, Alegre-Díaz, et al. Blood Pressure and Mortality in Mexico City: A Mendelian Randomization Study. Hypertension 2025; 82(11): 1896-905.

14. Thomson, Tapia-Conyer, Lacey et al. Low-intensity daily smoking and cause-specific mortality in Mexico: prospective study of 150,000 adults. Int J Epidemiol 2021; 50: 955-64.

15. Addey T, Alegre-Díaz J, Bragg F et al. Educational and social inequalities and cause-specific mortality in Mexico City: a prospective study. Lancet Public Health 2023; 8(9): e670-e679.

16. Trichia, Alegre-Díaz, Aguilar-Ramirez et al. Alcohol and mortality in Mexico: prospective study of 150 000 adults. Lancet Pub Health 2024; 9(11): e907-e915.

17. Aguilar-Ramirez, Tapia-Conyer, Herrington et al. Kidney function and mortality in Mexico: prospective study of 130 000 adults. Kid Med 2026; 101398.

18. Kuri-Morales, Emberson, Alegre Díaz et al. The prevalence of chronic diseases and major disease risk factors at different ages among 150 000 men and women living in Mexico City: cross-sectional analyses of a prospective study. BMC Public Health 2009, 9: 9.

19. Aguilar-Ramirez, Alegre-Díaz, Gnatiuc et al. Changes in the diagnosis and management of diabetes in Mexico City between 1998-2004 and 2015-19. Diabetes Care 2021; 44(4): 944-51

20. Gnatiuc, Alegre-Díaz, Halsey et al. Adiposity and Blood Pressure in 110 000 Mexican Adults. Hypertension 2017; 69: 608-14.

21. González-Carballo, Kuri-Morales, Chiquete, et al. Cognitive impairment at older ages among 8000 men and women living in Mexico City: cross-sectional analyses of a prospective study. BMC Public Health 2024; 24: 3620.

22. Aguilar-Ramirez, Alegre-Díaz, Herrington et al. Association of kidney function with NMR-quantified lipids, lipoproteins, and metabolic measures in Mexican adults. J Clin Endocrinol Metab 2021; 106(10): 2828-39.

23. Aguilar-Ramirez, Herrington, Alegre-Díaz et al. Adiposity and NMR-measure lipid and metabolic biomarkers among 30,000 Mexican adults. Commun Med 2022; 2: 143.

24. Ziyatdinov, Torres, Alegre-Díaz et al. Genotyping, sequencing and analysis of 140,000 adults from Mexico City. Nature 2023; 622: 784–93.

Sobre el estudio